Summary
To support the global community in its fight against the ongoing COVID-19 pandemic, G42 Healthcare commenced the world's first phase III clinical trial of an inactivated COVID-19 vaccine in July 2020. The phase III clinical trial considers the safety and effectiveness of the vaccine in a larger population sample. A compelling campaign is therefore necessary to mobilize volunteers and drive them to participate. Together with G42 Healthcare, APCO Worldwide (APCO) launched the #4Humanity programme that recruited 31,000 volunteers in six weeks,in the UAE alone. With only a few days from concept development to launch, G42 Healthcare and...